Fragasso Group Inc. Gilead Sciences, Inc. Transaction History

Fragasso Group Inc.

$1.24 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 08, 2024	SELL	$63.15 - $72.88 $13,324 - $15,377	-211 Reduced 6.26%	3,160 $216,000
Q1 2024 Apr 10, 2024	BUY	$71.58 - $87.29 $7,515 - $9,165	105 Added 3.21%	3,371 $246,000
Q4 2023 Jan 08, 2024	BUY	$73.27 - $83.09 $26,450 - $29,995	361 Added 12.43%	3,266 $264,000
Q3 2023 Dec 06, 2023	SELL	$73.94 - $80.67 $7,763 - $8,470	-105 Reduced 3.49%	2,905 $217,000
Q2 2023 Jul 10, 2023	BUY	$76.01 - $86.7 $8,665 - $9,883	114 Added 3.94%	3,010 $231,000
Q1 2023 Apr 13, 2023	BUY	$77.31 - $88.08 $21,724 - $24,750	281 Added 10.75%	2,896 $240,000
Q4 2022 Jan 24, 2023	BUY	$62.32 - $89.47 $162,966 - $233,964	2,615 New	2,615 $0
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $333,632 - $387,408	-4,612 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $2.13 Million - $2.73 Million	-34,076 Reduced 88.08%	4,612 $345,000
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $252,642 - $277,898	-4,100 Reduced 9.58%	38,688 $2.51 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $58,134 - $64,170	930 Added 2.22%	42,788 $2.71 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $125,967 - $141,257	2,036 Added 5.11%	41,858 $2.83 Million
Q1 2019 May 08, 2019	BUY	$62.53 - $70.05 $1.07 Million - $1.2 Million	17,089 Added 75.17%	39,822 $2.59 Million
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $787 - $1,027	-13 Reduced 0.06%	22,733 $1.42 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $396,530 - $439,031	5,563 Added 32.38%	22,746 $1.6 Million
Q2 2018 Aug 01, 2018	BUY	$64.88 - $75.68 $1,946 - $2,270	30 Added 0.17%	17,183 $1.22 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $175,398 - $213,830	2,408 Added 16.33%	17,153 $1.29 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $71,150 - $83,520	1,000 Added 7.28%	14,745 $1.06 Million
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $300,770 - $356,495	-4,171 Reduced 23.28%	13,745 $1.11 Million
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $1.29 Million - $1.53 Million	17,916	17,916 $1.45 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fragasso Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fragasso Group Inc. with notifications on news.

Account